Literature DB >> 21818118

HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway.

L Qiang1, T Wu, H-W Zhang, N Lu, R Hu, Y-J Wang, L Zhao, F-H Chen, X-T Wang, Q-D You, Q-L Guo.   

Abstract

Hypoxia induces the expansion of glioblastoma stem cells (GSCs), but the mechanism underlying it is still unclear. Here, we supply evidence that hypoxia-inducible factor-1α (HIF-1α) induced activation of Notch pathway is essential for hypoxia-mediated maintenance of GSC. Either depletion of HIF-1α or inactivation of Notch signaling partly inhibits the hypoxia-mediated maintenance of GSC. Further data suggest a role for HIF-1α in the interaction and stabilization of intracellular domain of Notch (NICD), and activation of Notch signaling. The mRNA level of HIF-1α and Notch target gene FABP7 was elevated in GSC. And the STAT3 pathway responsible for the HIF-1α gene transcription, the phosphatidylinositol 3-kinase-Akt and ERK1/2, both of which are contributed to HIF-1α protein translation, are also preferentially activated in GSC. Inhibition of these pathways partly reduces the hypoxia-induced activation of the Notch pathway and subsequent GSC maintenance. Taken together, our findings suggest that HIF-1α requires Notch pathway to drive the maintenance of GSC. The activated regulation of HIF-1α makes GSC more sensitive to hypoxia-mediated maintenance. These findings enhance our understanding of mechanism of hypoxia-mediated GSC expansion and provide HIF-1α as an attractive target for glioblastoma therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21818118      PMCID: PMC3263503          DOI: 10.1038/cdd.2011.95

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  43 in total

Review 1.  Notch signaling: cell fate control and signal integration in development.

Authors:  S Artavanis-Tsakonas; M D Rand; R J Lake
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

2.  Hypoxia requires notch signaling to maintain the undifferentiated cell state.

Authors:  Maria V Gustafsson; Xiaowei Zheng; Teresa Pereira; Katarina Gradin; Shaobo Jin; Johan Lundkvist; Jorge L Ruas; Lorenz Poellinger; Urban Lendahl; Maria Bondesson
Journal:  Dev Cell       Date:  2005-11       Impact factor: 12.270

3.  Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation.

Authors:  Evgenia V Gerasimovskaya; Doug A Tucker; Kurt R Stenmark
Journal:  J Appl Physiol (1985)       Date:  2004-10-22

4.  STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells.

Authors:  Joo Eun Jung; Hyun Gyu Lee; Ik Hyun Cho; Doo Hyun Chung; Sun-Hee Yoon; Young Mok Yang; Jung Weon Lee; Seongwon Choi; Jong-Wan Park; Sang-Kyu Ye; Myung-Hee Chung
Journal:  FASEB J       Date:  2005-05-26       Impact factor: 5.191

5.  Brain lipid-binding protein is a direct target of Notch signaling in radial glial cells.

Authors:  Todd E Anthony; Heather A Mason; Thomas Gridley; Gord Fishell; Nathaniel Heintz
Journal:  Genes Dev       Date:  2005-05-01       Impact factor: 11.361

6.  Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I.

Authors:  Caroline Treins; Sophie Giorgetti-Peraldi; Joseph Murdaca; Marie-Noëlle Monthouël-Kartmann; Emmanuel Van Obberghen
Journal:  Mol Endocrinol       Date:  2005-02-03

7.  Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.

Authors:  Toru Kondo; Takao Setoguchi; Tetsuya Taga
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-07       Impact factor: 11.205

8.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

9.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

10.  Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.

Authors:  Roser Buscà; Edurne Berra; Cédric Gaggioli; Mehdi Khaled; Karine Bille; Barbara Marchetti; Raphaël Thyss; Giorgos Fitsialos; Lionel Larribère; Corine Bertolotto; Thierry Virolle; Pascal Barbry; Jacques Pouysségur; Gilles Ponzio; Robert Ballotti
Journal:  J Cell Biol       Date:  2005-06-27       Impact factor: 10.539

View more
  123 in total

1.  Angiogenesis and the tumor space-time continuum.

Authors:  Guillaume Nugue; Didier Wion
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

2.  Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.

Authors:  Alessandro Cama; Fabio Verginelli; Lavinia Vittoria Lotti; Francesco Napolitano; Annalisa Morgano; Andria D'Orazio; Michele Vacca; Silvia Perconti; Felice Pepe; Federico Romani; Francesca Vitullo; Filippo di Lella; Rosa Visone; Massimo Mannelli; Hartmut P H Neumann; Giancarlo Raiconi; Carlo Paties; Antonio Moschetta; Roberto Tagliaferri; Angelo Veronese; Mario Sanna; Renato Mariani-Costantini
Journal:  Acta Neuropathol       Date:  2013-08-18       Impact factor: 17.088

3.  The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma.

Authors:  Hon-Kit Andus Wong; Rachid El Fatimy; Courtney Onodera; Zhiyun Wei; Ming Yi; Athul Mohan; Sindhuja Gowrisankaran; Priya Karmali; Eric Marcusson; Hiroaki Wakimoto; Robert Stephens; Erik J Uhlmann; Jun S Song; Bakhos Tannous; Anna M Krichevsky
Journal:  Mol Ther       Date:  2015-04-23       Impact factor: 11.454

4.  Hypoxia-inducible factor-1α regulates the expression of L-type voltage-dependent Ca(2+) channels in PC12 cells under hypoxia.

Authors:  Ran Li; Yong Wang; Zhaofei Yang; Yunling He; Tong Zhao; Ming Fan; Xuan Wang; Lingling Zhu; Xiaomin Wang
Journal:  Cell Stress Chaperones       Date:  2015-02-04       Impact factor: 3.667

Review 5.  Hes1: a key role in stemness, metastasis and multidrug resistance.

Authors:  Zi-Hao Liu; Xiao-Meng Dai; Bin Du
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

6.  The HIF-1 inhibitor YC-1 decreases reactive astrocyte formation in a rodent ischemia model.

Authors:  Jong-In Na; Joo-Young Na; Woo-Young Choi; Min-Cheol Lee; Man-Seok Park; Kang-Ho Choi; Jeong-Kil Lee; Kyung-Tae Kim; Jong-Tae Park; Hyung-Seok Kim
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

Review 7.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

Review 8.  The impact of age on oncogenic potential: tumor-initiating cells and the brain microenvironment.

Authors:  Elizabeth A Stoll; Philip J Horner; Robert C Rostomily
Journal:  Aging Cell       Date:  2013-06-28       Impact factor: 9.304

9.  Anti-diabetic effect of a novel oligosaccharide isolated from Rosa canina via modulation of DNA methylation in Streptozotocin-diabetic rats.

Authors:  Gholamreza Bahrami; Soraya Sajadimajd; Bahareh Mohammadi; Razieh Hatami; Shahram Miraghaee; Samira Keshavarzi; Mozafar Khazaei; Seyed Hamid Madani
Journal:  Daru       Date:  2020-08-03       Impact factor: 3.117

10.  Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents.

Authors:  Jiyoung Mun; Adnan Abdul Jabbar; Narra Sarojini Devi; Shaoman Yin; Yingzhe Wang; Chalet Tan; Deborah Culver; James P Snyder; Erwin G Van Meir; Mark M Goodman
Journal:  J Med Chem       Date:  2012-07-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.